I don't understand the FDA point either. Too bad. The

New Post Public Reply Private Reply Replies (3) Message Board
plutonium zeynoc #2077
684
I don't understand the FDA point either.

Too bad. The concept is very easy to understand.

This is my last post, so when I push the button, this is a good bye. All of the geniuses on this board can then talk all about share price. and bash KB because someone has to be to blame for shareholders' stock buying decisions.

In my humble opinion, when share price is all that is important, the posters become disconnected from the company and business DECN. Some never cared and it was always about share price. Nonetheless zeynoc I will explain the FDA issue for you.

DECN is demanding $400 - $700 million from J&J. Part of that demand results from a well founded belief that DECN's patents are being infringed by J&J's OneTouch Ultra and OneTouch Select diabetic test strips. OneTouch Select only sells in international markets. How stupid is that plan? Why would anyone sell a product internationally without developing a domestic market. Stupid, stupid, stupid. But for all of that stupidity J&J can be dumb all they want and continue to collect $300 million each year from primarily third world buyers for their OneTouch Select products. But I digress.

I have read all of the pleadings in four Federal lawsuits between DECN and J&J. Throughout all of those 6+ years of pleadings, J&J has played their message board theme: DECN sucks. Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders. Of the almost 700 Federal filings in these four Federal lawsuits, roughly 475 were filed by J&J and within all of those documents, the iHub message board opinions of DECN are manifest.

And now we come to Monday. Dr. Zem posted that there will be a hearing in Nevada Federal court. That much unfortunately is not true. At a hearing the lawyers, principals and attendees can see how the judge reacts to the pleadings and the oral arguments. At a hearing the judge might just dismiss the J&J Motion and force the litigants into Mediation. But alas, that is not the case. J&J will file their pile of steaming poop, and the judge will take until proobably the end of October to rule. So, what is true is that J&J gets one more written shot at convincing the judge that DECN sucks, Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders. And that is it. One lonely chance to overcome impossible (at this stage) odds.

I know that J&J will fail at this attempt. The lawyers for both sides know. The judge and his clerks (the real review professionals) all know this and have already made up their minds. The case will proceed, and the parties will be ordered to Mediation.

But my share price paramount friend zeynoc. Do you think the outcome of the Motion will be acceptable to J&J? Their goal is to drag the case out, lower their exposure (they believe time and foot dragging lowers liability -- and they may be right). Monday begins the first BIG strategic event. J&J has known since August 28 they were going to lose the Motion, and all that goes with it.

Court rulings are very, very important. J&J is going to lose this one and this one is BIG, but J&J is still J&J. So, if J&J's plan is to paint DECN like message board posters do: DECN sucks, Mr. Berman is a crook. DECN shareholders hate DECN, so any customers DECN has probably hate them too. DECN has no money and what money they do have was extorted from shareholders, etc. etc. then they are not going to just give up. The court case may move to third gear, but J&J's goal of destroying DECN has not changed.

So here comes the BIG point. What can J&J do that would have the same desired effect. that is, what can J&J do to force DECN to spend big money to survive. What can they do? They can go directly to the post-market group at the FDA and twist them against DECN like on steroids. And that would have the biggest desired effect because the J&J complaints (read: lies) are totally confidential. And the FDA would be only too happy to help out J&J, because FDA people in their mid to late-30s always look to move from the colorless government directly to the private sector, and what better place to work than J&J.

Now zeynoc, you have your own views about how the world works. But in these matters I actually have first hand experience -- many times over. Do you understand THAT? This will become all about the DARK SIDE of the industry if J&J loses in court. Take it to the bank, count on it.

So, let's do whatever we can to force out the only guy who beat J&J and the J&J influenced FDA. and that, in the share price paramount world would be justice. Let's force out the CEO and focus on the share price for the 90 days the company would have to live. I truly hope one or more shareholders come in and take over the company. I am a retired guy and I can afford my loss on DECN stock, so I would love to be a voyeur if shareholders move to force KB out and focus the company on share price.

And with that. Good bye.



1

Decision Diagnostics Corp (DECN) Stock Research Links

DECN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
High-Grade Copper Spurs Optimism for PolarX in Alaska

Updated Category News Views 4

Copper's New Pulse: PolarX Makes Waves in Alaska Ever hear about striking copper so rich it's practically shimmering? Well, PolarX Limited just might have hit that sweet spot up in the rugged expanses of Alaska. Let me tell you, when you're knee-deep in resources, like what they’re discovering at the Caribou Dome Project, it sure feels like you’ve struck modern-day...

Continue Reading
QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
2026 Buy-Side Index Reveals State Market Variance

Updated Category News Views 7

Toss out your one-size-fits-all real estate predictions; the Q2 2026 Buy-Side Index just unveiled some real whoppers about the housing market. What we're seeing isn't your typical year-over-year growth across the board. Nope, we're seeing splits as sharp as a knife between states. Some places are shooting up in price, while others seem to be stuck in mud. Price Surges and...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 12

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 6

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 8

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading

Top 5 Most Recently Viewed Articles

Paris Hilton's New Initiative for Pet Wellness Awareness Campaign

Updated Category News Views 258

Introducing a New Focus on Pet Wellness Pets hold a special place in our lives, serving not just as companions, but as beloved members of our families. A recent national campaign aims to enhance the well-being of pets by empowering pet owners and veterinarians with essential knowledge and resources. The core message is clear: prioritizing preventive care, high-quality...

Continue Reading
Investors Backing Stellantis May Pursue Legal Options Now

Updated Category News Views 45

Investigation into Stellantis N.V. for Investor Claims Faruqi & Faruqi, LLP is actively investigating potential claims on behalf of investors in Stellantis N.V. (NYSE: STLA). If you are someone who has faced losses exceeding $100,000 in Stellantis during the recent trading period, reaching out for guidance on your legal rights is highly recommended. Legal Assistance for...

Continue Reading
Diversified Energy Forms Partnership with Carlyle for $2 Billion Investment

Updated Category News Views 314

Diversified Energy and Carlyle Forge a Strategic Alliance BIRMINGHAM, Ala. and NEW YORK — Diversified Energy Company PLC (LSE: DEC; NYSE: DEC), a significant player in the production of natural gas and liquids, has announced a powerful partnership with Carlyle (NASDAQ: CG), a prominent global investment firm. This collaboration focuses on investing up to $2 billion in...

Continue Reading
T1 Energy's Exciting Q3 2025 Insights and Future Prospects

Updated Category News Views 358

T1 Energy's Preliminary Q3 2025 Results Overview T1 Energy Inc. (NYSE: TE), a leader in energy solutions, has provided a look into its preliminary financial and operational performance for the third quarter of 2025. This announcement sheds light on the significant developments and strategic directions the company is pursuing in the solar energy sector. Financial...

Continue Reading
Resecurity Strengthens Cybersecurity in META Through New Deal

Updated Category News Views 82

Resecurity Partners with emt Distribution META for Cybersecurity Solutions Resecurity, a provider of advanced cybersecurity solutions, has announced a significant partnership with emt Distribution META, a distinguished value-added distributor. This collaboration is aimed at enhancing cybersecurity across the META region, where businesses face increasing threats in the...

Continue Reading